
GC16421
Cediranib
Also listed as Cediranib (AZD217)
Cediranib (AZD217) (AZD2171) is a highly potent, orally available VEGFR tyrosine kinase inhibitor with IC50s of <1, <3, 5, 5, 36, 2 nM for Flt1, KDR, Flt4, PDGFRα, PDGFRβ, c-Kit, respectively
ChemicalCAS288383-20-0MW450.51FormulaC25H27FN4O3
- CAS number
- 288383-20-0
- Molecular weight
- 450.51
- Formula
- C25H27FN4O3
- Solubility
- ≥ 22·5mg/mL in DMSO
- InChIKey
- XXJWYDDUDKYVKI-UHFFFAOYSA-N
- Catalogue number
- GC16421
- Brand
- GLPBIO
Computed properties PubChem CID 9933475 · XLogP 4.9 · TPSA 72.5 Ų · H-bond donors 1
- XLogP
- 4.9
- TPSA
- 72.5 Ų
- H-bond donors
- 1
- H-bond acceptors
- 7
- Rotatable bonds
- 8
- Heavy atoms
- 33
SMILES CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5
Computed descriptors from PubChem (CID 9933475), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il